NYSE · Healthcare
Cadre Holdings, Inc. (CDRE)
As-reported financials and recent SEC filings for Cadre Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$610.3M
Net income
$44.1M
Net margin
7.2%
Diluted EPS
$1.02
ROE
13.9%
P/E (TTM)
33.4×
Market cap
$1.20B
Debt / equity
0.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $610.3M | $567.6M | $482.5M | $457.8M | $427.3M |
| Gross profit | $259.6M | $233.5M | $200.7M | $175.7M | $170.7M |
| Operating income | $67.4M | $66.8M | $56.5M | $16.7M | $51.7M |
| Net income | $44.1M | $36.1M | $38.6M | $5.8M | $12.7M |
| Diluted EPS | $1.02 | $0.90 | $1.02 | $0.16 | $0.44 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-23
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →SCHEDULE 13D/A2026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →Go deeper on CDRE
Search Cadre Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.